---
$id: https://graph.org.ai/products/commodity/51332830
$type: Product
source: UNSPSC
code: "51332830"
title: "Thioridazine"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thioridazine

**UNSPSC Code**: 51332830
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C21H26N2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N3D6TG58NI, chemically known as 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)- but generally known as thioridazine, which bears US NIH Compound Identifier 5452. European Medicines Agency schedules Thioridazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10984MIG. The term THIORIDAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules thioridazine in its Anatomical Therapeutic Chemical (ATC) Classification. THIORIDAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thioridazine under HS 29343010 and SITC 51578. As of Q4 2014, THIORIDAZINE remains the US FDA Preferred Term for this commodity. Thioridazine bears US NLM identifiers UMLS ID C0039943 and NCI Concept Code C61971. SMILES: S1C2C(N(CCC3N(CCCC3)C)C3C1CCCC3)CC(SC)CC2.

